Understanding cognitive reserve through genetics and genetic epidemiology

Cognitive Reserve: Theory and Applications

Volumn , Issue , 2013, Pages 5-36

  Lee, Joseph H ^a  

^a Taub Institute for Research on Alzheimer’s Disease and the Aging Brain Sergievsky Center College of Physicians and Surgeons Department of Epidemiology School of Public Health Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84920592155     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4324/9780203783047     Document Type: Chapter

References (165)

1. Ando, J., Ono, Y., & Wright, M. J. (2001). Genetic structure of spatial and verbal working memory. Behavioral Genetics, 31(6), 615–624.
2. Andreasen, N. C., Flaum, M., Swayze, V., 2nd, O’Leary, D. S., Alliger, R., Cohen, G., et al. (1993). Intelligence and brain structure in normal individuals. American Journal of Psychiatry, 150(1), 130–134.
3. Athan, E. S., Williamson, J., Ciappa, A., Santana, V., Romas, S. N., Lee, J. H., et al. 2001. A founder mutation in presenilin 1 causing early-onset Alzheimer disease in unrelated Caribbean Hispanic families. Journal of the American Medical Association, 56(18), 2257–2263.
4. Auer, J., Lamm, G., & Eber, B. (2004). Homocysteine as a predictive factor for hip fracture in older persons. New England Journal of Medicine, 557(10), 1027–1030.
5. Backman, L., Ginovart, N., Dixon, R. A., Wahlin, T. B., Wahlin, A., Halldin, C., et al. 2000. Age-related cognitive deficits mediated by changes in the striatal dopamine system. American Journal of Psychiatry, 757(4), 635–637.
6. Bales, K. R., Verina, T., Cummins, D. J., Du, Y., Dodel, R. C., Saura, J., et al. (1999). Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer’s disease. Proceedings of the National Academy of Science USA, 96(26), 15233–15238.
7. Barde, Y. A. (1994). Neurotrophins: A family of proteins supporting the survival of neurons. Progress in Clinical and Biological Research, 390, 45–56.
8. Barrett-Connor, E., & Goodman-Gruen, D. (1999). Cognitive function and endogenous sex hormones in older women. Journal of the American Geriatric Society, 47(11), 1289–1293.
9. Barrett-Connor, E., & Kritz-Silverstein, D. (1993). Estrogen replacement therapy and cognitive function in older women. Journal of the American Medical Association, 269(20), 2637–2641.
10. Bauer, A., Boschmann, N., Green, D., & Kuehnast, K. (1998). A generation at risk: Children in the Central Asian Republic of Kazakhstan and Kyrgyzstan. Manila, Philippines: Asian Development Bank.
11. Benfante, R. (1992). Studies of cardiovascular disease and cause-specific mortality trends in Japanese-American men living in Hawaii and risk factor comparisons with other Japanese populations in the Pacific region: A review. Human Biology, 64(6), 791–805.
12. Benton, A. L., Eslinger, P. J., & Damasio, A. R. (1981). Normative observations on neuropsychological test performances in old age. Journal of Clinical Neuropsychology, 5(1), 33–42.
13. Bertram, L., Blacker, D., Mullin, K., Keeney, D., Jones, J., Basu, S., et al. (2000). Evidence for genetic linkage of Alzheimer’s disease to chromosome lOq. Science, 290(5500), 2302–2303.
14. Bigio, E. H., Hynan, L. S., Sontag, E., Satumtira, S., & White, C. L. (2002). Synapse loss is greater in presenile than senile onset Alzheimer disease: Implications for the cognitive reserve hypothesis. Neuropathology and Applied Neurobiology, 28, 218–227.
15. Blacker, D., Bertram, L., Saunders, A. J., Moscarillo, T. J., Albert, M. S., Wiener, H., et al. (2003). Results of a high-resolution genome screen of 437 Alzheimer’s disease families. Human Molecular Genetics, 72(1), 23–32.
16. Bond, J., Roberts, E., Mochida, G. H., Hampshire, D. J., Scott, S., Askham, J. M., et al. (2002). Aspm is a major determinant of cerebral cortical size. Nature Genetics, Published online 23 September 2002, doi: 10.1038/ng995.
17. Borenstein Graves, A., Mortimer, J. A., Bowen, J. D., McCormick, W. C., McCurry, S. M., Schellenberg, G. D., et al. (2001). Head circumference and incident Alzheimer’s disease: Modification by apolipoprotein E. Neurology, 57(8), 1453–1460.
18. Brandi, M. L., Becherini, L., Gennari, L., Racchi, M., Bianchetti, A., Nacmias, B., et al. (1999). Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer’s disease. Biochemical and Biophysical Research Communications, 265(2), 335–338.
19. Brenner, S. (1997). Telomeres and telomerase (Vol. 211). New York: John Wiley and Sons.
20. Bryan, J., Osendarp, S., Hughes, D., Calvaresi, E., Baghurst, K., & van Klinken, J. W. (2004). Nutrients for cognitive development in school-aged children. Nutrition Reviews, 62(8), 295–306.
21. Bunce, D., Fratiglioni, L., Small, B. J., Winblad, B., & Backman, L. (2004). Apoe and cognitive decline in preclinical Alzheimer disease and non-demented aging. Neurology, 63(5), 816–821.
22. Buttini, M., Orth, M., Bellosta, S., Akeefe, H., Pitas, R. E., Wyss-Coray, T., et al. (1999). Expression of human apolipoprotein s3 or e4 in the brains of APOE-/-mice: Isoform-specific effects on neurodegeneration. Journal of Neuroscience, 79(12), 4867–4880.
23. Byrne, P. C., McMonagle, P., Webb, S., Fitzgerald, B., Parfrey, N. A., & Hutchinson, M. (2000). Age-related cognitive decline in hereditary spastic paraparesis linked to chromosome 2p. Neurology, 54(1), 1510–1517.
24. Chakravarti, A. (1999). Population genetics-making sense out of sequence. Nature Geneties, 21(Suppl.), 56–60.
25. Chapman, S., & Michaelson, D. M. (1998). Specific neurochemical derangements of brain projecting neurons in apolipoprotein E-deficient mice. Journal of Neurochemistry, 70(2), 708–714.
26. Christensen, H., Mackinnon, A., Jorm, A. F., Henderson, A. S., Scott, L. R., & Korten, A. E. (1994). Age differences and interindividual variation in cognition in community-dwelling elderly. Psychology and Aging, 9(3), 381–390.
27. Christensen, H., Mackinnon, A. J., Korten, A. E., Jorm, A. F., Henderson, A. S., Jacomb, P, et al. (1999). An analysis of diversity in the cognitive performance of elderly community dwellers: Individual differences in change scores as a function of age. Psychology and Aging, 14(2), 365–379.
28. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C, Small, G. W., et al. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science, 26(5123), 921–923.
29. Cruts, M. (2002). Alzheimer Disease Mutation Database.
30. Dale, P. S., Simonoff, E., Bishop, D. V., Eley, T. C., Oliver, B., Price, T. S., et al. (1998). Genetic influence on language delay in two-year-old children. Nature Neuroscience, 1(4), 324–328.
31. Deary, I. J., Whiteman, M. C., Pattie, A., Starr, J. M., Hayward, C., Wright, A. F., et al. (2002). Cognitive change and the APOE s4 allele. Nature, 418, 932.
32. Desai, P., Nebes, R., Dekosky, S. T., & Kamboh, M. I. (2005). Investigation of the effect of brain-derived neurotrophic factor (BDNF) polymorphisms on the risk of late-onset Alzheimer’s disease (AD) and quantitative measures of AD progression. Neuroscience Letters, 379(3), 229–234.
33. Detterman, D. K., Thompson, L. A., & Plomin, R. (1990). Differences in heritability across groups differing in ability. Behavior Genetetics, 20(3), 369–384.
34. Devlin, B., Daniels, M., & Roeder, K. (1997). The heritability of IQ. Nature, 355(6641), 468–471.
35. Dodart, J. C., Mathis, C., Bales, K. R., Paul, S. M., & Ungerer, A. (2000). Behavioral deficits in APP(V717F) transgenic mice deficient for the apolipoprotein E gene. Neuroreport, 11(3), 603–607.
36. Drachman, D. A. (2002). Hat size, brain size, intelligence, and dementia: What morphometry can tell us about brain function and disease. Neurology, 59(2), 156–157.
37. Duthie, S. J., Whalley, L. J., Collins, A. R., Leaper, S., Berger, K., & Deary, I. J. (2002). Homocysteine, B vitamin status, and cognitive function in the elderly. American Journal of Clinical Nutrition, 75(5), 908–913.
38. Edland, S. D., Xu, Y., Plevak, M., O’Brien, P, Tangalos, E. G., Petersen, R. C., et al. 2002. Total intracranial volume: Normative values and lack of association with Alzheimer’s disease. Neurology, 59(2), 272–274.
39. Egan, M. E, Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., et al. (2003). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell, 112(2), 257–269.
40. Enard, W., Przeworski, M., Fisher, S. E., Lai, C. S., Wiebe, V., Kitano, T., et al. (2002). Molecular evolution of FOXP2, a gene involved in speech and language. Nature, doi:10.1038/nature01025.
41. Ertekin-Taner, N., Graff-Radford, N., Younkin, L. H., Eckman, C., Baker, M., Adamson, J., et al. (2000). Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer’s disease pedigrees. Science, 290(5500), 2303–2304.
42. Ertekin-Taner, N., Ronald, J., Asahara, H., Younkin, L., Hella, M., Jain, S., et al. 2003. Fine mapping of the alpha-T catenin gene to a quantitative trait locus on chromosome 10 in late-onset Alzheimer’s disease pedigrees. Human Molecular Genetics, 12(23), 3133–3143.
43. Ertekin-Taner, N., Ronald, J., Feuk, L., Prince, J., Tucker, M., Younkin, L., et al. (2005). Elevated amyloid beta protein (Abeta42) and late onset Alzheimer’s disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene. Human Molecular Genetics, 14(3), 447–460.
44. Falconer, D. S., & Mackay, T. F C. (1996). Introduction to quantitative genetics(4th ed.). Burnt Mill, Harlow, UK: Longman.
45. Farrer, L. A., Cupples, L. A., Haines, J. L., Hyman, B., Kukull, W. A., Mayeux, R., et al. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. Apoe and Alzheimer Disease Meta Analysis Consortium. Journal of the American Medical Association, 275(16), 1349–1356.
46. Fisher, P. J., Turic, D., Williams, N. M., McGuffin, P., Asherson, P., Ball, D., et al. (1999). Dna pooling identifies QTLs on chromosome 4 for general cognitive ability in children. Human Molecular Genetics, 5(5), 915–922.
47. Flood, J. F, & Morley, J. E. (2000). Age-related changes in learning, memory, and memory processing. In J. E. Morley, H. J. Armbrecht, R. M. Coe, & B. Vellas (Eds.), The science of geriatrics (Vol. 2, pp. 503–514). Paris: Serdi Publisher.
48. Foster, N. L., Minoshima, S., & Kuhl, D. E. (1999). Brain imaging in Alzheimer disease. In R. D. Terry, R. Katzman, K. L. Bick, & S. S. Sisodia (Eds.), Alzheimer disease (2nd ed., pp. 67–93). Philadelphia: Lippincott Williams & Wilkins.
49. Gecz, J., & Mulley, J. (2000). Genes for cognitive function: Developments on the X. Genome Research, 10(2), 157–163.
50. Genoux, D., Haditsch, U., Knobloch, M., Michalon, A., Storm, D., & Mansuy, M. M. (2002). Protein phosphatase 1 is a molecular constrain on learning and memory. Nature, 418, 970–975.
51. Gordon, I., Ben-Eliyahu, S., Rosenne, E., Sehayek, E., & Michaelson, D. M. (1996). Derangement in stress response of apolipoprotein E-deficient mice. Neuroscience Letters, 206(2–3), 212–214.
52. Grady, C. L., Horwitz, B., Pietrini, R, Mentis, M. J., Ungerleiter, L., Rapoport, S. I., et al. (1996). Effect of task difficulty on cerebral blood flow during perceptual matching of faces. Human Brain Mapping, 4, 227–239.
53. Grasby, P. M., Frith, C. D., Friston, K. J., Simpson, J., Fletcher, P. C., Frackowiak, R. S., et al. (1994). A graded task approach to the functional mapping of brain areas implicated in auditory-verbal memory. Brain, 117 (6), 1271–1282.
54. Graves, A. B., Mortimer, J. A., Larson, E. B., Wenzlow, A., Bowen, J. D., & McCormick, W. C. (1996). Head circumference as a measure of cognitive reserve. Association with severity of impairment in Alzheimer’s disease. British Journal of Psychiatry, 169(1), 86–92.
55. Haan, M. N., Shemanski, L., Jagust, W. J., Manolio, T. A., & Kuller, L. (1999). The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. Journal of the American Medical Association, 282(1),4CM-6.
56. Hariri, A. R., Goldberg, T. E., Mattay, V. S., Kolachana, B. S., Callicott, J. H., Egan, M. F., et al. (2003). Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. Journal of Neuroscience, 23(17), 6690–6694.
57. Helkala, E. L., Koivisto, K., Hanninen, T., Vanhanen, M., Kervinen, K., Kuusisto, J., et al. (1995). The association of apolipoprotein E polymorphism with memory: A population based study. Neuroscience Letters, 191(3), 141–144.
58. Henderson, V. W., Paganini-Hill, A., Miller, B. L., Elble, R. J., Reyes, P. F., Shoupe, D., et al. (2000). Estrogen for Alzheimer’s disease in women: Randomized, doubleblind, placebo-controlled trial. Neurology, 54(2), 295–301.
59. Heyman, A., Wilkinson, W. E., Stafford, J. A., Helms, M. J., Sigmon, A. H., & Weinberg, T. (1984). Alzheimer’s disease: A study of epidemiological aspects. Annals of Neurology, 15(4), 335–341.
60. Honig, L. S., Schupf, N., Lee, J. H., Tang, M. X. & Mayeux, R. (2006). Short telomere length is associated with mortality in those with APOE4 and dementia. Annals of Neurology, 60, 181–187.
61. Isoe-Wada, K., Maeda, M., Yong, J., Adachi, Y., Harada, H., Urakami, K., et al. (1999). Positive association between an estrogen receptor gene polymorphism and Parkinson’s disease with dementia. European Journal of Neurology, 6(4), 431–435.
62. Jacobs, D. M., Tang, M. X., Stern, Y., Sano, M., Marder, K., Bell, K. L., et al. (1998). Cognitive function in nondemented older women who took estrogen after menopause. Neurology, 50(2), 368–373.
63. Jensen, A. R., & Marisi, D. Q. (1979). A note on the heritability of memory span. Behavioral Genetics, 9(5), 379–387.
64. Ji, Y., Urakami, K., Wada-Isoe, K., Adachi, Y., & Nakashima, K. (2000). Estrogen receptor gene polymorphisms in patients with Alzheimer’s disease, vascular dementia and alcohol-associated dementia. Dementia & Geriatric Cognitive Disorders, 11(3), 119–122.
65. Josselyn, S. A., Shi, C., Carlezon, W. A., Jr., Neve, R. L., Nestler, E. J., & Davis, M. 2001. Long-term memory is facilitated by cAMP response element-binding protein overexpression in the amygdala. Journal of Neuroscience, 21(1), 2404–2412.
66. Katzman, R. (1993). Education and the prevalence of dementia and Alzheimer’s disease. Neurology, 43(1), 13–20.
67. Katzman, R., Terry, R., DeTeresa, R., Brown, T., Davies, P., Fuld, R, et al. (1988). Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques. Annals of Neurology, 23(2), 138–144.
68. Kawas, C., Resnick, S., Morrison, A., Brookmeyer, R., Corrada, M., Zonderman, A., et al. (1997). A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study of Aging. Neurology, 48(6), 1517–1521.
69. Kawas, C. H., & Katzman, R. (1999). Epidemiology of dementia and Alzheimer’s disease. In R. D. Terry, K. L. Katzman, & S. S. Sisodia (Eds.), Alzheimer disease(2nd ed., pp. 95–116). Philadelphia: Lippincott Williams and Wilkins.
70. Koubova, J., & Guarente, L. (2003). How does calorie restriction work? Genes and Development, 17(3), 313–321.
71. Kruglyak, L. (1999). Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nature Genetics, 22(2), 139–144.
72. Lai, C. S., Fisher, S. E., Hurst, J. A., Vargha-Khadem, F., & Monaco, A. P. (2001). A forkhead-domain gene is mutated in a severe speech and language disorder. Nature, 413(6855), 519–523.
73. Lander, E. S., & Schork, N. J. (1994). Genetic dissection of complex traits. Science, 265(5181), 2037–2048.
74. Laws, S. M., Clarnette, R. M., Taddei, K., Martins, G., Paton, A., Almeida, O. R, et al. (2002). Association between the presenilin-1 mutation Glu318Gly and complaints of memory impairment. Neurobiology of Aging, 23(1), 55–58.
75. Lee, C. K., Klopp, R. G., Weindruch, R., & Prolla. T. A. (1999). Gene expression profile of aging and its retardation by caloric restriction. Science, 235(5432), 1390–1393.
76. Lee, J. H., Mayeux, R., Mayo, D., Mo, J., Santana, V., Williamson, J., et al. (2004). Fine mapping of lOq and 18q for familial Alzheimer’s disease in Caribbean Hispanics. Molecular Psychiatry, 9(11), 1042–1051.
77. Lee, J. H., Mayo, D., Mo, J., Santana, V., Williamson, J., Flaquer, A., et al. (2004). Fine mapping of 10 using memory and neuropsychological phenotypes in the Caribbean Hispanics. Neurobiology of Aging, 25(2), S56.
78. Levy-Lahad, E., & Bird, T. D. (1996). Genetic factors in Alzheimer’s disease: A review of recent advances. Annals of Neurology, 40(6), 829–840.
79. Levy-Lahad, E., Wijsman, E. M., Nemens, E., Anderson, L., Goddard, K. A., Weber, J. L., et al. (1995). A familial Alzheimer’s disease locus on chromosome 1. Science, 269(5226), 970–973.
80. Li, Y. J., Oliveira, S. A., Xu, R, Martin, E. R., Stenger, J. E., Scherzer, C. R., et al. (2003). Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. Human Molecular Genetics, 12(24), 3259–3267.
81. Li, Y. J., Scott, W. K„ Hedges, D. J„ Zhang, F„ Gaskell, P. C„ Nance, M. A., et al. 2003. Age at onset in two common neurodegenerative diseases is genetically controlled. American Journal of Human Genetics, 70(4), 985–993.
82. Luchsinger, J. A., & Mayeux, R. (2004). Dietary factors and Alzheimer’s disease. Lancet Neurology, 3(10), 579–587.
83. Luchsinger, J. A., Tang, M. X., Stern, Y., Shea, S., & Mayeux, R. (2001). Diabetes mellitus and risk of Alzheimer’s disease and dementia with stroke in a multiethnic cohort. American Journal of Epidemiology, 154(7), 635–641.
84. MacLullich, A. M., Ferguson, K. J., Deary, I. J., Seckl, J. R., Starr, J. M., & Wardlaw, J. M. (2002). Intracranial capacity and brain volumes are associated with cognition in healthy elderly men. Neurology, 59(2), 169–174.
85. Manly, J. J., Jacobs, D. M., Sano, M., Bell, K., Merchant, C. A., Small, S. A., et al. (1998). Cognitive test performance among nondemented elderly African Americans and whites. Neurology, 50(5), 1238–1245.
86. Markowska, A. L., & Savonenko, A. (2002). Retardation of cognitive aging by lifelong diet restriction: Implications for genetic variance. Neurobiology of Aging, 23(1), 75–86.
87. Marlow, A. J., Fisher, S. E., Richardson, A. J., Francks, C., Talcott, J. B., Monaco, A. R, et al. (2001). Investigation of quantitative measures related to reading disability in a large sample of sib-pairs from the UK. Behavior Genetics, 31(2), 219–230.
88. Mattila, K. M., Axelman, K., Rinne, J. O., Blomberg, M., Lehtimaki, T., Laippala, R, et al. (2000). Interaction between estrogen receptor 1 and the epsilon4 allele of apolipoprotein E increases the risk of familial Alzheimer’s disease in women. Neuroscience Letters, 282(1–2), 45–48.
89. Mattson, M. P. (2003A). Gene-diet interactions in brain aging and neurodegenerative disorders. Annals of Internal Medicine, 139(5 Pt 2), 441–144.
90. Mattson, M. P. (2003B). Will caloric restriction and folate protect against AD and PD? Neurology, 60(4), 690–695.
91. Mayeux, R., Lee, J. H., Romas, S. N., Mayo, D., Santana, V., Williamson, J., et al. (2002). Chromosome-12 mapping of late-onset Alzheimer disease among Caribbean Hispanics. American Journal of Human Genetics, 70(1), 237–243.
92. Mayeux, R., Ottman, R., Maestre, G., Ngai, C., Tang, M. X., Ginsberg, H., et al. (1995). Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer’s disease. Neurology, 45(3 Pt 1), 555–557.
93. Mayeux, R., Ottman, R., Tang, M. X., Noboa-Bauza, L., Marder, K., Gurland, B., et al. (1993). Genetic susceptibility and head injury as risk factors for Alzheimer’s disease among community-dwelling elderly persons and their first-degree relatives. Annals of Neurology, 33(5), 494–501.
94. Mayeux, R., Small, S. A., Tang, M., Tycko, B., & Stern, Y. (2001). Memory performance in healthy elderly without Alzheimer’s disease: Effects of time and apolipoprotein-E. Neurobiology of Aging, 22(4), 683–689.
95. Mayford, M., & Kandel, E. R. (1999). Genetic approaches to memory storage. Trends in Genetics, 75(11), 463–170.
96. McClearn, G. E., Johansson, B., Berg, S., Pedersen, N. L., Ahern, F., Petrill, S. A., et al. (1997). Substantial genetic influence on cognitive abilities in twins 80 or more years old. Science, 276(5318), 1560–1563.
97. McEwen, B. S., & Alves, S. E. (1999). Estrogen actions in the central nervous system. Endocrine Reviews, 20(2), 279–307.
98. Meaney, M. J., O’Donnell, D., Rowe, W., Tannenbaum, B., Steverman, A., Walker, M., et al. (1995). Individual differences in hypothalamic-pituitary-adrenal activity in later life and hippocampal aging. Experimental Gerontology, 30(3–4), 229–251.
99. Mejia, S., Pineda, D., Alvarez, L. M., & Ardila, A. (1998). Individual differences in memory and executive function abilities during normal aging. International Journal of Neuroscience, 95(3–4), 271–284.
100. Mori, E., Hirono, N., Yamashita, H., Imamura, T., Ikejiri, Y., Ikeda, M., et al. (1997). Premorbid brain size as a determinant of reserve capacity against intellectual decline in Alzheimer’s disease. American Journal of Psychiatry, 154(1), 18–24.
101. Mortimer, J. A., French, L. R., Hutton, J. T., & Schuman, L. M. (1985). Head injury as a risk factor for Alzheimer’s disease. Neurology, 35(2), 264–267.
102. Mulnard, R. A., Cotman, C. W., Kawas, C., van Dyck, C. H., Sano, M., Doody, R., et al. (2000). Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: A randomized controlled trial. Alzheimer’s Disease Cooperative Study. Journal of the American Medical Association, 283(8), 1007–1015.
103. Myers, A., Holmans, P., Marshall, H., Kwon, J., Meyer, D., Ramie, D., et al. (2000). Susceptibility locus for Alzheimer’s disease on chromosome 10. Science, 290(5500), 2304–2305.
104. Newbury, D. F., Bonora, E., Lamb, J. A., Fisher, S. E., Lai, C. S., Baird, G., et al. (2002). Foxp2 is not a major susceptibility gene for autism or specific language impairment. American Journal of Human Genetics, 70(5), 1318–1327.
105. Olson, J. M., Goddard, K. A., & Dudek, D. M. (2001). The amyloid precursor protein locus and very-late-onset Alzheimer disease. American Journal of Human Genetics, 459(4), 895–899.
106. Ostlund, H., Keller, E., & Hurd, Y. L. (2003). Estrogen receptor gene expression in relation to neuropsychiatric disorders. Annals of the New York Academy of Science, 1007, 54–63.
107. Ott, J. (1999). Analysis of human genetic linkage (3rd ed.). Baltimore: Johns Hopkins University Press.
108. Payami, H., Grimslid, H., Oken, B., Camicioli, R., Sexton, G., Dame, A., et al. (1997). A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): Effects of family history and apolipoprotein E genotype. American Journal of Human Genetics, 60(4), 948–956.
109. Pericak-Vance, M. A., Bass, M. P, Yamaoka, L. H., Gaskell, R C., Scott, W. K., Terwedow, H. A., et al. (1997). Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. Journal of the American Medical Association, 278(15), 1237–1241.
110. Pericak-Vance, M. A., Bebout, J. L., Gaskell, P. C., Jr., Yamaoka, L. H., Hung, W. Y., Alberts, M. J., et al. (1991). Linkage studies in familial Alzheimer disease: Evidence for chromosome 19 linkage. American Journal of Human Genetics, 48(6), 1034–1050.
111. Pericak-Vance, M. A., Grubber, J., Bailey, L. R., Hedges, D., West, S., Santoro, L., et al. (2000). Identification of novel genes in late-onset Alzheimer’s disease. Experimental Gerontology, 35(9–10), 1343–1352.
112. Petanceska, S. S., Nagy, V., Frail, D., & Gandy, S. (2000). Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer’s amyloid beta peptides in brain. Neurology, 54(12), 2212–2217.
113. Petrill, S. A., Luo, D., Thompson, L. A., & Detterman, D. K. (1996). The independent prediction of general intelligence by elementary cognitive tasks: Genetic and environmental influences. Behavior Genetics, 26(2), 135–147.
114. Petrill, S. A., Thompson, L. A., & Detterman, D. K. (1995). The genetic and environmental variance underlying elementary cognitive tasks. Behavior Genetics, 25(3), 199–209.
115. Plomin, R., Pedersen, N. L., Lichtenstein, R, & McClearn, G. E. (1994). Variability and stability in cognitive abilities are largely genetic later in life. Behavior Genetics, 24(3), 207–215.
116. Powell, D. H., & Whitla, D. K. (1994). Profiles in cognitive aging. Cambridge, MA: Harvard University Press.
117. Raber, J., Wong, D., Buttini, M., Orth, M., Bellosta, S., Pitas, R. E., et al. (1998). Isoform-specific effects of human apolipoprotein E on brain function revealed in APOE knockout mice: Increased susceptibility of females. Proceedings of the National Academy of Science, USA, 95(18), 10914–10919.
118. Reich, D. E., Cargill, M., Bolk, S., Ireland, J., Sabeti, P C., Richter, D. J., et al. (2001). Linkage disequilibrium in the human genome. Nature, 411(6834), 199–204.
119. Risch, N., & Merikangas, K. (1996). The future of genetic studies of complex human diseases. Science, 275(5281), 1516–1517.
120. Roberts, G. W., Gentleman, S. M., Lynch, A., Murray, L., Landon, M., & Graham, D. I. (1994). Beta amyloid protein deposition in the brain after severe head injury: Implications for the pathogenesis of Alzheimer’s disease. Journal of Neurology, Neurosurgery & Psychiatry, 57(4), 419–425.
121. Rogaev, E. I., Sherrington, R., Rogaeva, E. A., Levesque, G., Ikeda, M., Liang, Y., et al. (1995). Familial Alzheimer’s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer’s disease type 3 gene. Nature, 576(65 43), 775–778.
122. Rogaeva, E., Premkumar, S., Song, Y., Sorbi, S., Brindle, N., Paterson, A., et al. (1998). Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity. Journal of the American Medical Association, 280(1), 614–618.
123. Rogaeva, E. A., Fafel, K. C., Song, Y. Q., Medeiros, H., Sato, C., Liang, Y., et al. (2001). Screening for PS1 mutations in a referral-based series of AD cases: 21 novel mutations. Neurology, 57(4), 621–625.
124. Sahota, A., Yang, M., Gao, S., Hui, S. L., Baiyewu, O., Gureje, O., et al. (1997). Apolipoprotein E-associated risk for Alzheimer’s disease in the African-American population is genotype dependent. Annals of Neurology, 42(4), 659–661.
125. Sarbayev, B. T., Kudaibergenov, Z., Chuyenbekova, A., & Imanbayev, D. (1999). Nutrition of women and children. In T. S. Sharmanov (Ed.), Kazakhstan demographic and health survey1999. Calverton, MD: Academy of Preventive Medicine & Macro International Inc.
126. Satz, R (1993). Brain reserve capacity on symptom onset after brain injury: A formulation and review of evidence for threshold theory. Neuropsychology, 7, 273–295.
127. Schaie, K. W. (1988). Variability in cognitive function in the elderly: Implications for societal participation. Basic Life Sciences, 43, 191–211.
128. Schellenberg, G. D., Bird, T. D., Wijsman, E. M., Orr, H. T., Anderson, L., Nemens, E„ et al. (1992). Genetic linkage evidence for a familial Alzheimer’s disease locus on chromosome 14. Science, 255(5082), 668–671.
129. Schofield, P. W., Logroscino, G., Andrews, H. F., Albert, S., & Stern, Y. (1997). An association between head circumference and Alzheimer’s disease in a population-based study of aging and dementia. Neurology, 49(1), 30–37.
130. Schofield, P. W., Mosesson, R. E., Stern, Y., & Mayeux, R. (1995). The age at onset of Alzheimer’s disease and an intracranial area measurement. A relationship. Archives of Neurology, 52(1), 95–98.
131. Schork, N. J., Fallin, D., & Lanchbury, J. S. (2000). Single nucleotide polymorphisms and the future of genetic epidemiology. Clinical Genetics, 55(4), 250–264.
132. Schupf, N., Kapell, D., Lee, J. Fl, Zigman, W., Canto, B., Tycko, B., et al. (1996). Onset of dementia is associated with apolipoprotein E epsilon4 in Down’s syndrome. Annals of Neurology, 40(5), 799–801.
133. Scott, W. K., Grubber, J. M., Conneally, P. M., Small, G. W., Hulette, C. M., Rosenberg, C. K., et al. (2000). Fine mapping of the chromosome 12 late-onset Alzheimer disease locus: Potential genetic and phenotypic heterogeneity. American Journal of Human Genetics, 66(3), 922–932.
134. Sharmanov, T. S. (1999). Kazakhstan demographic and health survey 1999. Calverton, MD: Academy of Preventive Medicine & Macro International, Inc.
135. Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., et al. (1995). Cloning of a gene bearing missense mutations in early-onset familial Alzheimer’s disease. Nature, 575(6534), 754–760.
136. Silva, A. J., & Josselyn, S. A. (2002). The molecules of forgetfulness. Nature, 475(6901), 929–930.
137. Singh, M., Meyer, E. M., Millard, W. J., & Simpkins, J. W. (1994). Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Research, 644(2), 305–312.
138. Small, B. J., Rosnick, C. B., Fratiglioni, L., & Backman, L. (2004). Apolipoprotein E and cognitive performance: A meta-analysis. Psychology and Aging, 19(4), 592–600.
139. Small, G. W., Ercoli, L. M., Silverman, D. H., Huang, S. C., Komo, S., Bookheimer, S. Y., et al. (2000). Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer’s disease. Proceedings of the National Academy of Science, USA, 97(11), 6037–6042.
140. Small, S. A., Wu, E. X., Bartsch, D., Perera, G. M., Lacefield, C. O., DeLaPaz, R., et al. (2000). Imaging physiologic dysfunction of individual hippocampal subregions in humans and genetically modified mice. Neuron, 25(3), 653–664.
141. St. George-Hyslop, P. H. (2000). Molecular genetics of Alzheimer’s disease. Biological Psychiatry, 47(3), 183–199.
142. Stern, Y. (2002). What is cognitive reserve? Theory and research application of the reserve concept. Journal of the International Psychological Society, 5(3), 448–160.
143. Stern, Y., Albert, S., Tang, M. X., & Tsai, W. Y. (1999). Rate of memory decline in AD is related to education and occupation: Cognitive reserve? Neurology, 53(9),1942–1947.
144. Stern, Y., Alexander, G. E., Prohovnik, I., & Mayeux, R. (1992). Inverse relationship between education and parietotemporal perfusion deficit in Alzheimer’s disease. Annals of Neurology, 32(3), 371–375.
145. Stern, Y., Brandt, J., Albert, M., Jacobs, D. M., Liu, X., Bell, K., et al. (1997). The absence of an apolipoprotein epsilon4 allele is associated with a more aggressive form of Alzheimer’s disease. Annals of Neurology, 41(5), 615–620.
146. Stern, Y., Gurland, B., Tatemichi, T. K., Tang, M. X., Wilder, D., & Mayeux, R. (1994). Influence of education and occupation on the incidence of Alzheimer’s disease. Journal of the American Medical Association, 276(13), 1004–1010.
147. Strachan, T., & Read, A. R (1999). Human molecular genetics 2 (2nd ed.). New York: Wiley-Liss.
148. Swan, G. E., & Carmelli, D. (2002). Evidence for genetic mediation of executive control: A study of aging male twins. Journals of Gerontology Series B: Psychological Sciences and Social Sciences, 57(2), 133–143.
149. Swan, G. E., Carmelli, D., Reed, T., Harshfield, G. A., Fabsitz, R. R., & Eslinger, R J. (1990). Heritability of cognitive performance in aging twins. The National Fleart, Lung, and Blood Institute Twin Study. Archives of Neurology, 47(3), 259–262.
150. Tang, M. X., Jacobs, D., Stern, Y., Marder, K., Schofield, P., Gurland, B., et al. (1996). Effect of oestrogen during menopause on risk and age at onset of Alzheimer’s disease. Lancet, 348(9025), 429–432.
151. Tang, M. X., Stern, Y., Marder, K., Bell, K., Gurland, B., Lantigua, R., et al. (1998). The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. Journal of the American Medical Association, 279(10), 751–755.
152. Terwilliger, J. D., Goring, H. H. H., Magnusson, R K. E., & Lee, J. H. (2002). Study design for genetic epidemiology and gene mapping: The Korean diaspora project. Life Science Research, 6(2), 95–115.
153. Thapar, A., Petrill, S. A., & Thompson, L. A. (1994). The heritability of memory in the Western Reserve Twin Project. Behavior Genetics, 24(2), 155–160.
154. Thompson, P. M., Cannon, T. D., Narr, K. L., van Erp, T., Poutanen, V. P., Huttunen, M., et al. (2001). Genetic influences on brain structure. Nature Neuroscience, 4(12), 1253–1258.
155. Unverzagt, F. W., Hui, S. L., Farlow, M. R., Hall, K. S., & Hendrie, H. C. (1998). Cognitive decline and education in mild dementia. Neurology, 50(1), 181–185.
156. Van Broeckhoven, C., Backhovens, H., Cruts, M., De Winter, G., Bruyland, M., Cras, R, et al. (1992). Mapping of a gene predisposing to early-onset Alzheimer’s disease to chromosome 14q24.3. Nature Genetics, 2(4), 335–339.
157. van Duijn, C. M., Tanja, T. A., Haaxma, R., Schulte, W., Saan, R. J., Lameris, A. J., et al. (1992). Head trauma and the risk of Alzheimer’s disease. American Journal of Epidemiology, 135(7), 775–782.
158. Weel, A. E., Uitterlinden, A. G., Westendorp, I. C., Burger, H., Schuit, S. C., Hofman, A., et al. (1999). Estrogen receptor polymorphism predicts the onset of natural and surgical menopause. Journal of Clinical Endocrinology & Metabolism, 84(9), 3146–3150.
159. Williams, R. W., Strom, R. C., & Goldowitz, D. (1998). Natural variation in neuron number in mice is linked to a major quantitative trait locus on Chr 11. Journal of Neuroscience, 41(1), 138–146.
160. Wilson, R. S., Schneider, J. A., Barnes, L. L., Beckett, L. A., Aggarwal, N. T., Cochran, E. J., et al. (2002). The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period. Archives of Neurology, 59(1),1154–1160.
161. Wu, W. S., Holmans, P., Wavrant-DeVrieze, F., Shears, S., Kehoe, P., Crook, R., et al. (1998). Genetic studies on chromosome 12 in late-onset Alzheimer disease. Journal of the American Medical Association, 280(1), 619–622.
162. Yaffe, K., Haan, M., Byers, A., Tangen, C., & Kuller, L. (2000). Estrogen use, APOE, and cognitive decline: Evidence of gene-environment interaction. Neurology, 54(10), 1949–1954.
163. Yaffe, K., Lui, L. Y, Grady, D., Cauley, J., Kramer, J., & Cummings, S. R. (2000). Cognitive decline in women in relation to non-protein-bound oestradiol concentrations. Lancet, 356(9231), 708–712.
164. Yaffe, K., Sawaya, G., Lieberburg, I., & Grady, D. (1998). Estrogen therapy in postmenopausal women: Effects on cognitive function and dementia. Journal of the American Medical Association, 279(9), 688–695.
165. Yin, J. C, Del Vecchio, M., Zhou, H., & Tully, T. (1995). Creb as a memory modulator: Induced expression of a dCREB2 activator isoform enhances long-term memory in Drosophila. Cell, 31(1), 107–115.